<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: pancreatic ductal adenocarcinoma cancer</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Scientists find new molecule to target in pancreatic cancer treatment</title>
   	 <description>Researchers at Mayo Clinic in Florida have identified a new target to improve treatment of pancreatic ductal adenocarcinoma cancer, which accounts for more than 95 percent of pancreatic cancer cases. This fast-growing, often lethal cancer is resistant to conventional chemotherapy. The findings are published in the Jan. 3 online issue of PLOS ONE.</description>
     <link>http://medicalxpress.com/news/2013-01-scientists-molecule-pancreatic-cancer-treatment.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 03 Jan 2013 17:00:01 EST</pubDate>
	 <guid isPermaLink="false">news276433930</guid>
	 
</item>
<item>
     <title>Mutated Kras spins a molecular loop that launches pancreatic cancer</title>
   	 <description>Scientists have connected two signature characteristics of pancreatic cancer, identifying a self-perpetuating &quot;vicious cycle&quot; of molecular activity and a new potential target for drugs to treat one of the most lehal forms of cancer.</description>
     <link>http://medicalxpress.com/news/2012-01-mutated-kras-molecular-loop-pancreatic.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 26 Jan 2012 10:29:06 EST</pubDate>
	 <guid isPermaLink="false">news246796113</guid>
	 
</item>


</channel>
</rss>
